These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression. Sougioultzis S; Simeonidis S; Bhaskar KR; Chen X; Anton PM; Keates S; Pothoulakis C; Kelly CP Biochem Biophys Res Commun; 2006 Apr; 343(1):69-76. PubMed ID: 16529714 [TBL] [Abstract][Full Text] [Related]
6. Characterization of alpha,alpha-trehalase released in the intestinal lumen by the probiotic Saccharomyces boulardii. Buts JP; Stilmant C; Bernasconi P; Neirinck C; De Keyser N Scand J Gastroenterol; 2008; 43(12):1489-96. PubMed ID: 18777247 [TBL] [Abstract][Full Text] [Related]
7. Transduction pathways regulating the trophic effects of Saccharomyces boulardii in rat intestinal mucosa. Buts JP; De Keyser N Scand J Gastroenterol; 2010; 45(2):175-85. PubMed ID: 19958054 [TBL] [Abstract][Full Text] [Related]
12. Molecular tools for differentiating probiotic and clinical strains of Saccharomyces cerevisiae. Posteraro B; Sanguinetti M; Romano L; Torelli R; Novarese L; Fadda G Int J Food Microbiol; 2005 Sep; 103(3):295-304. PubMed ID: 16099314 [TBL] [Abstract][Full Text] [Related]
13. Probiotic agent Saccharomyces boulardii reduces the incidence of lung injury in acute necrotizing pancreatitis induced rats. Karen M; Yuksel O; Akyürek N; Ofluoğlu E; Cağlar K; Sahin TT; Paşaoğlu H; Memiş L; Akyürek N; Bostanci H J Surg Res; 2010 May; 160(1):139-44. PubMed ID: 19375719 [TBL] [Abstract][Full Text] [Related]
14. Diversity of Czerucka D; Rampal P World J Gastroenterol; 2019 May; 25(18):2188-2203. PubMed ID: 31143070 [TBL] [Abstract][Full Text] [Related]
15. Effects of exopolysaccharide-producing probiotic strains on experimental colitis in rats. Sengül N; Aslím B; Uçar G; Yücel N; Işik S; Bozkurt H; Sakaoğullari Z; Atalay F Dis Colon Rectum; 2006 Feb; 49(2):250-8. PubMed ID: 16362802 [TBL] [Abstract][Full Text] [Related]
16. Towards understanding molecular modes of probiotic action. Marco ML; Pavan S; Kleerebezem M Curr Opin Biotechnol; 2006 Apr; 17(2):204-10. PubMed ID: 16510275 [TBL] [Abstract][Full Text] [Related]
17. Dietary omega-3 fatty acids and cholesterol modify desaturase activities and fatty acyl constituents of rat intestinal brush border and microsomal membranes of diabetic rats. Keelan M; Thomson AB; Garg ML; Wierzbicki E; Wierzbicki AA; Clandinin MT Diabetes Res; 1994; 26(2):47-66. PubMed ID: 7554726 [TBL] [Abstract][Full Text] [Related]
18. Yeasts as probiotics: Mechanisms, outcomes, and future potential. Sen S; Mansell TJ Fungal Genet Biol; 2020 Apr; 137():103333. PubMed ID: 31923554 [TBL] [Abstract][Full Text] [Related]
19. Saccharomyces boulardii CNCM I-745: A Non-bacterial Microorganism Used as Probiotic Agent in Supporting Treatment of Selected Diseases. Kaźmierczak-Siedlecka K; Ruszkowski J; Fic M; Folwarski M; Makarewicz W Curr Microbiol; 2020 Sep; 77(9):1987-1996. PubMed ID: 32472262 [TBL] [Abstract][Full Text] [Related]
20. Gastroprotective effect of Saccharomyces boulardii in a rat model of ibuprofen-induced gastric ulcer. Girard P; Coppé MC; Pansart Y; Gillardin JM Pharmacology; 2010; 85(3):188-93. PubMed ID: 20185968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]